Clinical Trial Update: Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and immunogenicity of two HIV vaccines (SeV-G(NP) and Ad35-GRIN) given intranasally and intramuscularly in prime-boost regimens i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ad35-GRIN HIV Vaccine (Ad35-GRIN HIV Vaccine)
• SeV-G(NP) HIV Vaccine (SeV-G(NP) HIV Vaccine)

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV Infections | Phase 1 | Status: COMPLETED